Ascendis Pharma A/S EV/Sales
Was ist das EV/Sales von Ascendis Pharma A/S?
EV/Sales von Ascendis Pharma A/S ist 189.58
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Ascendis Pharma A/S
Was macht Ascendis Pharma A/S?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Unternehmen mit ev/sales ähnlich Ascendis Pharma A/S
- EHR Resources hat EV/Sales von 184.58
- Epic hat EV/Sales von 184.92
- Eastern Iron hat EV/Sales von 186.43
- Mangalam Industrial Finance hat EV/Sales von 186.75
- BH Macro hat EV/Sales von 187.03
- Sequana Medical NV hat EV/Sales von 188.84
- Ascendis Pharma A/S hat EV/Sales von 189.58
- New Millennium Iron Corp hat EV/Sales von 190.74
- SA Multimicrocloud hat EV/Sales von 191.05
- Diatreme Resources hat EV/Sales von 191.08
- Chinook Therapeutics hat EV/Sales von 191.16
- Celldex Therapeutics hat EV/Sales von 191.44
- Momenta Pharmaceuticals hat EV/Sales von 191.59